1Yang H, Wang H, Czura CJ, Tracey KJ. HMGB1 as a cytokine and therapeutic target. J Endotoxin Res 2002, 8: 469-72.
2Wang H, Tracey KJ. High mobility group box 1 (HMGB1). Crit Care Med 2005, 33: S472-4.
3Brezniceanu ML, Volp K, Bosser S, Solbach C, Lichter P, Joos S, et al. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J 2003, 17: 1295-7.
4Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2002, 2: 910-7.
5van Deursen JM. Rb loss causes cancer by driving mitosis mad.Cancer Cell 2007, 11: 1-3.
6Delston RB, Harbour JW. Rb at the interface between cell cycle and apoptotic decisions. Curr Mol Med 2006, 6: 713-8.
7Stevaux O, Dyson NJ. A revised picture of the E2F transcrip tional network and RB function. Curr Opin Cell Biol 2002, 14: 684-91.
8Helt AM, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcino genesis 2003, 24: 159-69.
9Gabellini C, Del Bufalo D, Zupi G. Involvement of RB gene family in tumor angiogenesis. Oncogene 2006, 25: 5326-32.
10De Falco G, Giordano A. pRb2/p130: a new candidate for retino blastoma tumor formation. Oncogene 2006, 25: 5333-40.
7Wang H,Bloom O,Zhang M,et al.HMG-1 as a late mediator of endotoxin lethality in mice.Science,1999,285:248-251.
8Bonaldi T,Talamo F,Scaffidi P,et al.Monocytic cells hyperace-tylate chromatin protein HMCB1 to redirect it towards secretion.EMBO J,2003,22:5551-5560.
9Handa Y,Kabuto M,Kobayashi H,et al.The correlation between immulogical reaction in the arterial wall and the time course of the develpment of cerebral vaso-spasm in a primate model Neurosurgery,1999,28:542-549.
10Aihara Y,Kasuya H,Onda H,et al.Quantitative analysis of gem expressions related to inflammation in caninc spastic artery after subarachnoid hemorrhage.Stroke,2001,32:212-217.
